| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jian Fei Qin CEO | XSHE Exchange | CNE1000032V9 ISIN |
| CN Country | 2,522 Employees | 29 May 2025 Last Dividend | 13 Jun 2018 Last Split | - IPO Date |
Harbin Medisan Pharmaceutical Co., Ltd., founded in 1996 and headquartered in Harbin, China, is deeply entrenched in the pharmaceutical industry, focusing on the research, development, production, and sale of pharmaceutical products and medical devices within China. The company has carved a niche for itself by offering a wide range of pharmaceutical products catering to various health needs, alongside its venture into the cosmetics market. As a testament to its expansive approach, Harbin Medisan not only emphasizes the production of essential medication but also ensures to cover a broad spectrum of health-related concerns through its diversified product lineup.
Harbin Medisan Pharmaceutical Co., Ltd. offers a comprehensive portfolio of products and services designed to meet a wide variety of health care needs, including: